How often do you take Mounjaro (tirzepatide)?

Mounjaro® is an injectable medication that you take once weekly. Mounjaro is available in six doses. Start at a dose of 2.5 mg once per week for the first month, then increase the weekly dose to 5 mg for your second month, followed by an increase to 7.5 mg in month three, 10 mg in month four, 12.5 mg in month five, and finally up to 15 mg - the highest dose currently available - for the sixth month onward. However, not everyone needs the maximum dose to meet their health goals. As it is FDA-approved for the treatment of type 2 diabetes, it is recommended to continue to increase each month if not meeting blood sugar goals. However, it may be recommended by your medical provider to further increase the dose even if you are meeting those goals as the medication can also promote additional weight loss, especially at higher doses. It is important to check in with your medical provider with each step up in dose to track your progress and monitor for any side effects.

Learn more about Mounjaro prescribing information and how Form Health doctors prescribe Mounjaro to help patients achieve their health goals.

ABOUT THE AUTHOR

Nathaniel Pedley, MD, ABOM Diplomate

Dr. Nathaniel Pedley is an internist and obesity medicine specialist who is passionate about supporting patients in achieving their health goals. He attended Amherst College in Massachusetts for undergrad, and completed a post-baccalaureate in pre-medical studies at Columbia University. He continued at Columbia University for medical school and went on to complete his residency in internal medicine at UCLA where he served as a Project Lead for the UCLA Department of Medicine Quality Team and a peer mentor to junior residents.

Doctor, healthy food,  man on a computer , and smiling women sitting on counter in baggy yellow sweatshirt

Find your Form

Take the first step to your healthier future.

Get Started
Disclaimer: The content made available on The Form Health Website represents the views and opinions of the authors and not those of other entities, such as the manufacturers of products mentioned therein.  

Mounarjo® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.